Pfizer Buys 40% of Brazilian Drug Maker Teuto

by Savitha.C.Muppala on  October 23, 2010 at 12:42 AM Corporate News
  •   Print
  •   Share
  •   Comments
  •  Text 
Pfizer, US pharmaceutical giant, has bought 40 percent of Brazilian drug company Teuto for a whopping 238 million dollars.

The purchase could lead to the 100-percent acquisition of Teuto in 2014, it said in a statement.

The 40-percent stake "allows Pfizer to increase its participation in Brazil's pharmaceutical market," the head of Pfizer Brazil, Victor Mezei, said in the statement.

He explained that the deal could result in Teuto producing generic versions of Pfizer medicines, and Pfizer using Teuto products in its output.

Pfizer is the world's second-biggest pharmaceutical company in the world after US rival Johnson & Johnson, according to Fortune magazine.

The maker of Viagra to treat erectile dysfunction and Lipitor to lower cholesterol, it had 2009 revenues of 50 billion dollars and profits of 8.6 billion dollars.

Pfizer Brazil generated 703 million dollars in revenues last year.

Source-AFP

 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X
  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
News Categories:  
Obesity Health Center

Corporate Related News

» Sun Pharma’s ANDA for Azelastine Nasal Spray Gets FDA Nod » Mylan’s ANDA for Clopidogrel Tablets Gets FDA Approval
» Drug Marketing: Abbott Labs Fined $1.6 Billion » The Cancer Cell Line Encyclopedia Launched by Novartis
» LeGoo Maker Pluromed to be Acquired by Sanofi » NGOs Protest Against Novartis' Glivec Lawsuit in India
» Allscripts Expanding India Operations » Bio-Tech Medicine Proves to be Attractive for TCG Lifesciences
Read More >>